New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

We hoped industry layoffs would relent in ... Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to 30% of the company’s total staffers—along ...

The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...

Short interest for healthcare stocks in S&P 500 rose slightly in January vs. December, while Moderna continued to be the most ...

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...

Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...

Bhopal: Chief minister Mohan Yadav said on Friday that Madhya Pradesh is emerging as a global hub for industrial investment and strategic innovation.